| HCPCS G1028 | Take-home supply of nasal naloxone; 2-pack of 8mg per 0.1 ml nasal spray (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to code for primary procedure | Current code | 8 hospitals |
|---|
| HCPCS G2078 | Take-home supply of methadone; up to 7 additional day supply (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to code for primary procedure | Current code | 8 hospitals |
|---|
| HCPCS G2079 | Take-home supply of buprenorphine (oral); up to 7 additional day supply (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to code for primary procedure | Current code | 8 hospitals |
|---|
| HCPCS G2215 | Take-home supply of nasal naloxone; 2-pack of 4mg per 0.1 ml nasal spray (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to code for primary procedure | Current code | 16 hospitals |
|---|
| HCPCS G9017 | Amantadine hydrochloride, oral, per 100 mg (for use in a medicare-approved demonstration project) | Retired code | 1 hospital |
|---|
| HCPCS G9019 | Oseltamivir phosphate, oral, per 75 mg (for use in a medicare-approved demonstration project) | Retired code | 1 hospital |
|---|
| HCPCS G9033 | Amantadine hydrochloride, oral brand, per 100 mg (for use in a medicare-approved demonstration project) | Retired code | none yet |
|---|
| HCPCS G9035 | Oseltamivir phosphate, oral, brand, per 75 mg (for use in a medicare-approved demonstration project) | Retired code | none yet |
|---|
| HCPCS J0572 | Buprenorphine/naloxone, oral, less than or equal to 3 mg buprenorphine | Current code | 22 hospitals |
|---|
| HCPCS J0573 | Buprenorphine/naloxone, oral, greater than 3 mg, but less than or equal to 6 mg buprenorphine | Current code | 25 hospitals |
|---|
| HCPCS J0574 | Buprenorphine/naloxone, oral, greater than 6 mg, but less than or equal to 10 mg buprenorphine | Current code | 25 hospitals |
|---|
| HCPCS J0575 | Buprenorphine/naloxone, oral, greater than 10 mg buprenorphine | Current code | 21 hospitals |
|---|
| HCPCS J1811 | Insulin (fiasp) for administration through dme (i.e., insulin pump) per 50 units | Current code | 26 hospitals |
|---|
| HCPCS J1813 | Insulin (lyumjev) for administration through dme (i.e., insulin pump) per 50 units | Current code | 26 hospitals |
|---|
| HCPCS J2545 | Pentamidine isethionate, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per 300 mg | Current code | 31 hospitals |
|---|
| HCPCS J7302 | Levonorgestrel-releasing intrauterine contraceptive system, 52 mg | Retired code | none yet |
|---|
| HCPCS J7307 | Etonogestrel (contraceptive) implant system, including implant and supplies | Current code | 46 hospitals |
|---|
| HCPCS J7308 | Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | Current code | 28 hospitals |
|---|
| HCPCS J7309 | Methyl aminolevulinate (mal) for topical administration, 16.8%, 1 gram | Retired code | 11 hospitals |
|---|
| HCPCS J7310 | Ganciclovir, 4.5 mg, long-acting implant | Retired code | 16 hospitals |
|---|
| HCPCS J7311 | Injection, fluocinolone acetonide, intravitreal implant (retisert), 0.01 mg | Current code | 33 hospitals |
|---|
| HCPCS J7312 | Injection, dexamethasone, intravitreal implant, 0.1 mg | Current code | 28 hospitals |
|---|
| HCPCS J7340 | Carbidopa 5 mg/levodopa 20 mg enteral suspension, 100 ml | Current code | 28 hospitals |
|---|
| HCPCS J7604 | Acetylcysteine, inhalation solution, compounded product, administered through dme, unit dose form, per gram | Current code | none yet |
|---|
| HCPCS J7608 | Acetylcysteine, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per gram | Current code | 45 hospitals |
|---|
| HCPCS J7622 | Beclomethasone, inhalation solution, compounded product, administered through dme, unit dose form, per milligram | Current code | none yet |
|---|
| HCPCS J7626 | Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 0.5 mg | Current code | 46 hospitals |
|---|
| HCPCS J7627 | Budesonide, inhalation solution, compounded product, administered through dme, unit dose form, up to 0.5 mg | Current code | 5 hospitals |
|---|
| HCPCS J7633 | Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per 0.25 milligram | Current code | 7 hospitals |
|---|
| HCPCS J7634 | Budesonide, inhalation solution, compounded product, administered through dme, concentrated form, per 0.25 milligram | Current code | none yet |
|---|
| HCPCS J7637 | Dexamethasone, inhalation solution, compounded product, administered through dme, concentrated form, per milligram | Current code | none yet |
|---|
| HCPCS J7638 | Dexamethasone, inhalation solution, compounded product, administered through dme, unit dose form, per milligram | Current code | none yet |
|---|
| HCPCS J7639 | Dornase alfa, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram | Current code | 36 hospitals |
|---|
| HCPCS J7665 | Mannitol, administered through an inhaler, 5 mg | Current code | 13 hospitals |
|---|
| HCPCS J7676 | Pentamidine isethionate, inhalation solution, compounded product, administered through dme, unit dose form, per 300 mg | Current code | none yet |
|---|
| HCPCS J7682 | Tobramycin, inhalation solution, fda-approved final product, non-compounded, unit dose form, administered through dme, per 300 milligrams | Current code | 40 hospitals |
|---|
| HCPCS J7683 | Triamcinolone, inhalation solution, compounded product, administered through dme, concentrated form, per milligram | Current code | 7 hospitals |
|---|
| HCPCS J7685 | Tobramycin, inhalation solution, compounded product, administered through dme, unit dose form, per 300 milligrams | Current code | 8 hospitals |
|---|
| HCPCS J7699 | Noc drugs, inhalation solution administered through dme | Current code | 2 hospitals |
|---|
| HCPCS J7799 | Noc drugs, other than inhalation drugs, administered through dme | Current code | 1 hospital |
|---|
| HCPCS J7999 | Compounded drug, not otherwise classified | Current code | 24 hospitals |
|---|
| HCPCS M1145 | Most favored nation (mfn) model drug add-on amount, per dose, (do not bill with line items that have the jw modifier) | Retired code | 2 hospitals |
|---|